Is systemic lupus erythematosus a new risk factor for atherosclerosis?

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.creatorFreire, Beatriz Funayama Alvarenga-
Autor(es): dc.creatorDa Silva, Rogério Cardoso-
Autor(es): dc.creatorFabro, Alexandre Todorovic-
Autor(es): dc.creatorDos Santos, Daniela Cristina-
Data de aceite: dc.date.accessioned2025-08-21T22:16:47Z-
Data de disponibilização: dc.date.available2025-08-21T22:16:47Z-
Data de envio: dc.date.issued2022-04-29-
Data de envio: dc.date.issued2022-04-29-
Data de envio: dc.date.issued2006-01-01-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/231799-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/231799-
Descrição: dc.descriptionOBJECTIVE: To evaluate the prevalence of cardiovascular events (CVE) secondary to atherosclerosis in lupus patients and correlate them to the traditional risk factors, disease duration and drug therapy used. METHODS: A retrospective study was carried out based on data obtained from patients' charts. Patients included were those who had a lupus diagnosis confirmed at least two years before inclusion in the study and had been followed since 1992. CVE were characterized as MI, angina pectoris and stroke non-related to lupus activity. Risk factors and drugs used for treatment were recorded. RESULTS: Seventy-one charts were analyzed. Patients' mean age was 34.2±12.7 years; 68 were women and three were men; 58 were Caucasian (81.6%). Ten (14.08%) presented CVE. Patients in whom CVE were observed were older (42.7 vs. 32.8 years p=0.0021) and presented longer disease duration (10.8 vs. 7.2 years p=0.011). The traditional risk factors, daily and cumulative doses of steroids, immunosuppressive drugs and antimalarial drugs were not significant when patients with and without CVE were compared. CONCLUSION: The prevalence of CVE secondary to atherosclerosis in systemic lupus erythematosus (SLE) was 14.08%. The traditional risk factors were not associated with the development of CVE in lupus patients. Patients that presented cardiovascular events were older and presented longer disease duration. It is a premature conclusion to establish SLE as an independent risk factor for atherosclerosis development.-
Descrição: dc.descriptionFaculdade de Medicina de Botucatu UNESP, Botucatu, SP-
Descrição: dc.descriptionFaculdade de Medicina de Botucatu UNESP, Botucatu, SP-
Idioma: dc.languageen-
Idioma: dc.languagept_BR-
Relação: dc.relationArquivos Brasileiros de Cardiologia-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectAtherosclerosis-
Palavras-chave: dc.subjectCardiovascular disease-
Palavras-chave: dc.subjectSystemic lupus erythematosus-
Título: dc.titleIs systemic lupus erythematosus a new risk factor for atherosclerosis?-
Título: dc.titleLupus eritematoso sistêmico: Novo fator de risco para aterosclerose?-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.